Market sentiment signals for AbCellera Biologics (ABCL): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
11 analysts
Options Flow (P/C)
0.12
More calls — Bullish
Avg Consensus PT
$13
+6.1%
Highest Price Target
$30
+141.5%
Lowest Price Target
$4
-67.8%
Short Interest
12.8%
Declining — Bullish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Oct 12, 2026 | UBS | Alice Nettleton— | +44.9% | $18 | Initiate | Buy |
| Sep 29, 2026 | JP Morgan | Brian Cheng— | +36.9% | $17 | Initiate | Overweight |
